Dimenhydrinate

Dimenhydrinate
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Turky Alkathery, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Overview

Dimenhydrinate is an antiemetic that is FDA approved for the treatment of these symptoms associated with motion sickness:

• nausea
• vomiting
• dizziness. Common adverse reactions include nausea, vomiting, xerostomia and sedation..

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

• Uses for prevention and treatment of these symptoms associated with motion sickness:

• nausea
• vomiting
• dizziness

Dosage

This image is provided by the National Library of Medicine.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Dimenhydrinate in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Dimenhydrinate in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Indications

• Uses for prevention and treatment of these symptoms associated with motion sickness:

• nausea
• vomiting
• dizziness

• Do not use in children under 2 years of age unless directed by a doctor

Dosage

This image is provided by the National Library of Medicine.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Dimenhydrinate in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Dimenhydrinate in pediatric patients.

Contraindications

• None

Warnings

• None

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Dimenhydrinate Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Dimenhydrinate Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Dimenhydrinate Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Dimenhydrinate in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Dimenhydrinate in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Dimenhydrinate during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Dimenhydrinate in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Dimenhydrinate in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Dimenhydrinate in geriatric settings.

Gender

There is no FDA guidance on the use of Dimenhydrinate with respect to specific gender populations.

Race

There is no FDA guidance on the use of Dimenhydrinate with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Dimenhydrinate in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Dimenhydrinate in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Dimenhydrinate in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Dimenhydrinate in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Dimenhydrinate Administration in the drug label.

Monitoring

There is limited information regarding Dimenhydrinate Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Dimenhydrinate and IV administrations.

Overdosage

There is limited information regarding Dimenhydrinate overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Dimenhydrinate Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Dimenhydrinate Mechanism of Action in the drug label.

Structure

There is limited information regarding Dimenhydrinate Structure in the drug label.

Pharmacodynamics

There is limited information regarding Dimenhydrinate Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Dimenhydrinate Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Dimenhydrinate Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Dimenhydrinate Clinical Studies in the drug label.

How Supplied

There is limited information regarding Dimenhydrinate How Supplied in the drug label.

Storage

There is limited information regarding Dimenhydrinate Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Dimenhydrinate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

This image is provided by the National Library of Medicine.

This image is provided by the National Library of Medicine.

{{#ask: Label Page::Dimenhydrinate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Dimenhydrinate Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Dimenhydrinate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

• ®

Look-Alike Drug Names

dimenhyDRINATE - diphenhydrAMINE

• A® — B®

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.